Human LIGHT/TNFSF 14 enzyme-linked immunoassay kit
| Specification | 96 Test |
|---|---|
| Sensitivity | 0.02pg/ml (50 μl); 1.79pg/ml (10 μl); |
| Standard Curve Range | 1.37 ~1000 pg/ml |
| Standard Curve Gradient | 7 Points/3 Folds |
| Number of Incubations | 2 |
| Detectable sample | Liquid phase sample of soluble substances. For example: serum, plasma, cell culture supernatant, tissue grinding liquid, etc. |
| Sample Volume | 50 μl/10 μl |
| Type | Fully Ready-to-Use |
| Operation Duration | 120min |
| pg/ml | O.D. | Average | Corrected | |
|---|---|---|---|---|
| 0.00 | 0.0056 | 0.0054 | 0.0055 | |
| 1.37 | 0.0182 | 0.0157 | 0.0170 | 0.0115 |
| 4.12 | 0.0454 | 0.0464 | 0.0459 | 0.0404 |
| 12.35 | 0.1327 | 0.1317 | 0.1322 | 0.1267 |
| 37.04 | 0.3915 | 0.3874 | 0.3895 | 0.3840 |
| 111.11 | 1.0448 | 1.1238 | 1.0843 | 1.0788 |
| 333.33 | 2.6482 | 2.7299 | 2.6891 | 2.6836 |
| 1000.00 | 4.4024 | 4.5220 | 4.4622 | 4.4567 |
Precision
| Intra-assay Precision | Inter-assay Precision | |||||
| Sample Number | S1 | S2 | S3 | S1 | S2 | S3 |
| 22 | 22 | 22 | 6 | 6 | 6 | |
| Average(pg/ml) | 18.2 | 99.3 | 351.5 | 18.2 | 92.8 | 322.2 |
| Standard Deviation | 0.6 | 2.5 | 18.2 | 1.1 | 5.8 | 19.2 |
| Coefficient of Variation(%) | 3.3 | 2.5 | 5.2 | 6.2 | 6.3 | 5.9 |
Intra-assay Precision (Precision within an assay) Three samples of known concentration were tested twenty-two times on one plate to assess intra-assay precision. Inter-assay Precision (Precision between assays) Three samples of known concentration were tested six times on one plate to assess intra-assay precision.
Spike Recovery
The spike recovery was evaluated by spiking 3 levels of human LIGHT/TNFSF14 into health human serum sample. The un-spiked serum was used as blank in this experiment.
The recovery ranged from 80% to 99% with an overall mean recovery of 94%.
Sample Values
| Sample Matrix | Sample Evaluated | Range (pg/ml) | Detectable (%) | Mean of Detectable (pg/ml) |
|---|---|---|---|---|
| Serum | 30 | 1.30-7.01 | 100 | 3.49 |
Serum/Plasma – Thirty samples from apparently healthy volunteers were evaluated for the presence of human LIGHT/TNFSF14 in this assay. No medical histories were available for the donors. n.d. = non-detectable. Samples measured below the sensitivity are considered to be non-detectable.
Product Data Sheet
Background: LIGHT/TNFSF 14
LIGHT, also known as TNFSF14, is a homotrimeric glycoprotein in the TNF superfamily. It is expressed on the surface of activated lymphocytes, NK cells, immature dendritic cells, monocytes, and granulocytes. A soluble form can be shed by proteolysis. LIGHT binds and activates HVEM/TNFRSF14 to costimulate Th1 immune responses, enhance CD8+ T cell‑mediated tumor immunity, and regulate allogeneic T cell activation and allograft rejection. In addition, it binds and activates Lymphotoxin beta R/TNFRSF3 to induce apoptosis, cytokine production, mesenteric lymph node organogenesis, and maintenance of lymph node structure and function. It can also bind the soluble human decoy receptor DcR3/TNFRSF6B.
